Jost Marion, Wehkamp Ulrike
Department of Dermatology, Venerology and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Cancers (Basel). 2022 Mar 4;14(5):1324. doi: 10.3390/cancers14051324.
Since the 1970s, a connection between the skin's microbiota and cutaneous T-cell lymphomas (CTCL) was suggested. New techniques such as next-generation sequencing technologies enable the examination of the nuanced interplay between microbes and their host. The purpose of this review is an updated description of the current knowledge on the composition of the microbiome, relevant bacteria, or other stimuli, and their potential role in CTCL with a focus on the most frequent subtype, mycosis fungoides. Some findings suggest that the skin barrier-or the deficiency hereof-and host-microbiota might be involved in disease progression or etiopathogenesis. In addition, information on the current knowledge of antimicrobial peptide expression in CTCL, as well as treatment considerations with antiseptics and antibiotics, are included. Further studies are needed to provide more insight and potentially contribute to the development of new treatment approaches.
自20世纪70年代以来,皮肤微生物群与皮肤T细胞淋巴瘤(CTCL)之间的联系就已被提出。诸如新一代测序技术等新技术能够检测微生物与其宿主之间细微的相互作用。本综述的目的是更新关于微生物组组成、相关细菌或其他刺激因素的现有知识,以及它们在CTCL中潜在作用的描述,重点关注最常见的亚型——蕈样肉芽肿。一些研究结果表明,皮肤屏障——或其缺陷——以及宿主微生物群可能参与疾病进展或发病机制。此外,还包括CTCL中抗菌肽表达的现有知识,以及使用防腐剂和抗生素的治疗考虑因素。需要进一步研究以提供更多见解,并可能有助于开发新的治疗方法。